Form D · Other Health Care
CIVATECH ONCOLOGY, INC.
Morrisville, NC · CIK 0001373884
Offering snapshot reported Nov 19, 2021 · SEC filing
- Reported sold
- $7.94M Offering amount: $15.2M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 11, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 19, 2021 | Initial | $7,939,016 | No comparison | 47 | SEC filing |
| Dec 20, 2017 | Initial | $15,000 | No comparison | 1 | SEC filing |
| Aug 15, 2017 | Initial | $916,134 | No comparison | 9 | SEC filing |
| Dec 16, 2016 | Amendment | $2,710,220 | $1,080,219vs Apr 5, 2016 | 28 | SEC filing |
| Aug 10, 2016 | Initial | $10,000 | No comparison | 1 | SEC filing |
| Apr 5, 2016 | Initial | $1,630,001 | No comparison | 13 | SEC filing |
| Jul 29, 2014 | Amendment | $1,522,201 | $1,202,201vs Apr 28, 2014 | 16 | SEC filing |
| Apr 28, 2014 | Initial | $320,000 | No comparison | 2 | SEC filing |
| Jun 4, 2013 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Apr 23, 2013 | Amendment | $700,313 | $525,313vs Oct 6, 2011 | 14 | SEC filing |
| Mar 27, 2012 | Initial | $75,000 | No comparison | 2 | SEC filing |
| Oct 6, 2011 | Initial | $175,000 | No comparison | 5 | SEC filing |
| Mar 22, 2010 | Initial | $115,000 | No comparison | 4 | SEC filing |
| Nov 19, 2009 | Initial | $1,500 | No comparison | 1 | SEC filing |
| Jun 5, 2009 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Mar 4, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 10, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 18, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $159K
- Finders' fees
- $0
- Form D file number
- 021-421881
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| EuroConsult, Inc. | 143366 |
Source: Form D, filed Nov 19, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Suzanne Troxler Babcock | Director, Executive |
| James A. Beck | Director |
| Robert D. Black | Director, Executive |
| Claudia A. Black | Executive |
| Delwin Coufal | Director |
| Robert J. Greczyn | Director |
| Robert J. Greczyn, Jr. | Director |
| Herb Kuhn | Director |
| Tempe Lampe | Director |
| Jeremy K. Mario | Director |
| Carlton Midyette | Director |
| William Pully | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
627 Davis Drive Suite 200
Morrisville, NC, 27560
Morrisville, NC, 27560